Replies to post #261001 on Avid Bioservices Inc (CDMO)

[Protector]

jbainseky,

You wrote:

WOW, I didn't realize the Phase 2 MOS was that high!! And here I thought all along the phase 2 MOS was less than 12 months, what was I thinking?

Here it is, OS MOS 12.1 months for PII 2nd ln NSCLC and I took the combined arms because it was Stat. Sig otherwise it would have been 13+ months.

I wrote:

I think it is fair to say that after the salvaging the Sept 7th 2012 results (113% outperforming Docetaxel alone) is what PPHM knows Bavituximab can do, no matter whether they filed the conservative (their own words) 60% improvement to the FDA. Brekken confirmed at NYAS that the results of the PII were BETTER then what was filed. Officially at that point 60% is what the FDA goes on.

as an explanation why PPHM could DESIGN SUNRISE based on the Sept 7th 2012 announcement because that are the REAL results (hence OS MOS 12.1) no matter the fact that for the FDA they conservatively filed 60% improvement. And Dr. Brekken confirmed publicly at NYAS in a Q & A with the approval of CEO King and Shan who were standing at the side that the real results of SUNRISE were indeed better then what they took to the EOPII meeting with the FDA (because they didn't new that at the moment, salvaging was still going on).

So YES the OS MOS was that high, and actually on the 3mg/kg arm it was even higher.